Mod GRF 1-29
Mod GRF 1-29 is a peptide hormone (also known as a protein hormone) that was
developed in Canada and first mentioned in medical literature in 2005. It is a protein
that is 29 amino acids long and is a GHRH analogue. As a GHRH analogue, Mod
GRF 1-29 (CJC-1295 without DAC) acts on receptors at the pituitary gland to
stimulate the release of Human Growth Hormone. Mod GRF 1-29 acts upon
receptors located in the anterior pituitary gland, and signals the pituitary gland to
increase Human Growth Hormone production and cause a release of massive
quantities of Human Growth Hormone in a pulsatile manner. The effects of Mod GRF
1-29 are very similar from what would be expected from synthetic HGH
administration over the long term (see the Human Growth Hormone profile here),
although the amount of time that the released human growth hormone will remain in
circulation is of a far less amount of time than synthetic Human Growth Hormone
does. Therefore, multiple applications of Mod GRF 1-29 is recommended
throughout the day in order to simulate Human Growth Hormone levels that remain
high on a constant basis. Mod GRF 1-29 (CJC-1295 without DAC) is commonly
combined with a Ghrelin mimetic (also known as a GHRP — Growth Hormone
Releasing Hexapeptide), such as GHRP-6, GHRP-2, Hexarelin, or Ipamorelin in
order to initiate and amplify a greater pulse of HGH from the pituitary compared to
Mod GRF 1-29 used solitarily on its own. The effects of a GHRH analogue (such as
Mod GRF 1-29) and a Ghrelin mimetic (a GHRP such as GHRP-6 or Ipamorelin) are
synergistic and amplify the release of HGH.
Mod GRF 1-29 is a sterile, non-pyrogenic, white lyophilized powder intended for
subcutaneous or intramuscular injection, after reconstitution with sterile Water for
Mechanism of Action
As a result Mod GRF 1-29 Therapy, the increased volume of human growth
hormone (hGH) secreted by the stimulated pituitary gland is converted by the liver
into IGF-1. The increased amount of IGF-1 in the bloodstream results an increase in
metabolism and growth of new cells within the body’s organs and bones. This
treatment is prescribed for unlabeled use in adults to increase lean muscle mass,
reduce body fat, increase bone density, enhance the immune system, and
strengthen the heart, as well as, other organs of the body. Since the increased
volume of human growth hormone is produced by the body’s pituitary gland, the
body’s endocrine system will not allow more growth hormone to be produced by the
Mod GRF 1-29 stimulation of the pituitary than the body can safely process within
the endocrine self-monitoring system.
Positive results of Mod GRF 1-29 is very similar to recombinant human
growth hormone therapy results:
- Increases the development of lean body mass through the
development of new muscle cells
- Reduces body fat through lipolysis
- Increases energy and vitality
- Increases strength
- Increases endurance
- Accelerates healing from wounds or surgery
- Strengthens the heart
- Enhances the immune system
- Increases IGF-1 production
- Improves sleep quality
- Increases calcium retention, and strengthens and increases the
mineralization of bone or bone density.
- Increases protein synthesis and stimulates the growth of all internal
organs except the brain.
Hexarelin is generally very well tolerated by most individuals when used at the
recommended doses of up to 200mcg per injection.
- Temporary Redness of Face and Neck
- Difficulty Swallowing
- Head Pain
Instructions for reconstitution
Flip off the top of the peptide vial with your thumb. Use the alcohol swab to wipe the
rubber stopper of the peptide vial. Push the needle of the syringe into the middle of the
rubber stopper so it goes through the rubber and into the vial. Now, while angling the
needle so that the water for injection goes down the side of the glass, rather than
directly into the powder, inject the water for injection into the vial. Repeat this step until
you have the correct amount of water in the vial. The powder will dissolve quickly,
however it can help to gently roll the vial in between your fingers (do not shake the vial
vigorously). Remove the syringe and dispose of it. You should never reuse a syringe.
Recommended dosage of Mod GRF 1-29:
- 200 — 500 mg once per day.
- After reconstitution, may be stored for a maximum of 14 days in a refrigerator at 2°C — 8°C.
- Store vials in an upright position.
- Store in a refrigerator (2°C — 8°C). Keep in the outer carton in order to protect from light.
- For one month can be stored at room temperature.